发明名称 Isolation of human plasma procoagulant protein factor VIII from biological factors
摘要 A rapid and simple process for purifying human, bovine and porcine procoagulant protein Factor VIII on a large scale using sequential high performance size exclusion chromatography under, first, low salt concentration conditions and, second, under high salt concentration conditions from reconstituted commercial Factor VIII:C (complexed Factor VIII) concentrate. The chromatographic separation is carried out on a high performance size exclusion chromatographic column packed with porous beads having a particle size of from about 13 to about 35 microns, pore diameters of from about 500 to about 2000 Angstroms and a pore volume of from about 1.0 to about 1.8 ml per gram. The first chromatographic separation is carried in a buffered aqueous solution using the buffered aqueous solution as an eluant. The low molecular weight constituents (impurities) are separated from Factor VIII and the high molecular weight constituents (impurities). A second chromatographic separation may be carried out after Factor VIII has been dissociated in a buffered solution having a concentration of from about 0.25 to about 0.45M calcium ion. The second chromatographic column is packed with some packing as the first column and is eluted with a buffered aqueous solution containing 0.25 to 0.45M calcium ion. In a column of 2.5x60 cm, 4 gms of commercial Factor VIII concentrate can be purified in less than two hours. The process is amenable to scale up.
申请公布号 US4675385(A) 申请公布日期 1987.06.23
申请号 US19850716456 申请日期 1985.03.27
申请人 ALPHA THERAPEUTIC CORPORATION 发明人 HERRING, STEVEN W.
分类号 G01L9/12;C07K14/755;G01L9/00;(IPC1-7):A61K35/14;A61K35/16;C07K3/20 主分类号 G01L9/12
代理机构 代理人
主权项
地址